JPMorgan Chase & Co’s NeuroSense Therapeutics NRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,304
Closed -$1.9K 6603
2023
Q2
$1.9K Buy
+1,304
New +$1.9K ﹤0.01% 5442